Hospital-Based Management of Opioid Use Disorder in the Fentanyl Era—The Role and Limits of Expert Consensus

• by Itai Danovitch

• May 7, 2026

The Case for Continuous Monitoring for Sport Performance

Shane and Britton Needham speak from personal experience on the potential of wearable analytical devices for athletes 

• by James Strachan

• July 13, 2026

• 10 min

Upregulated FASN-mediated lipogenesis in senescent macrophages contributes to liver fibrosis progression

• by Hongliang Dong, Chuanfang Shu, Ran Liu, Mingpei Zhao, Kaiyue Zhang, Ziqun Qu, Lili Wang, Jing Fan, Wei Ye

• July 14, 2026

FDA Expands Bladder Cancer Regimen

KEYNOTE-B15/EV-304 demonstrated statistically significant improvements in event-free and overall survival with perioperative pembrolizumab plus enfortumab vedotin-ejfv compared with neoadjuvant gemcitabine plus cisplatin.

• by Kathryn Wighton

• July 10, 2026

• 2 min